Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 28 studies | 35% ± 14% | |
| fibroblast | 17 studies | 29% ± 13% | |
| endothelial cell of artery | 13 studies | 50% ± 18% | |
| capillary endothelial cell | 12 studies | 40% ± 21% | |
| endothelial cell of vascular tree | 12 studies | 35% ± 14% | |
| smooth muscle cell | 11 studies | 28% ± 13% | |
| pericyte | 11 studies | 25% ± 8% | |
| vein endothelial cell | 10 studies | 30% ± 18% | |
| endothelial cell of lymphatic vessel | 9 studies | 31% ± 15% | |
| enteroendocrine cell | 5 studies | 30% ± 10% | |
| adipocyte | 5 studies | 23% ± 5% | |
| connective tissue cell | 4 studies | 34% ± 12% | |
| myofibroblast cell | 4 studies | 20% ± 6% | |
| adventitial cell | 4 studies | 24% ± 11% | |
| pancreatic A cell | 3 studies | 29% ± 10% | |
| type B pancreatic cell | 3 studies | 36% ± 13% | |
| glomerular endothelial cell | 3 studies | 44% ± 13% | |
| retinal ganglion cell | 3 studies | 48% ± 18% | |
| precursor B cell | 3 studies | 28% ± 12% | |
| pro-B cell | 3 studies | 32% ± 4% | |
| epithelial cell | 3 studies | 39% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 96% | 47278.08 | 555 / 578 | 92% | 103.71 | 1064 / 1155 |
| breast | 99% | 69833.34 | 456 / 459 | 88% | 89.12 | 979 / 1118 |
| pancreas | 83% | 18307.59 | 272 / 328 | 98% | 288.89 | 174 / 178 |
| thymus | 92% | 22787.66 | 601 / 653 | 85% | 72.01 | 516 / 605 |
| ovary | 77% | 25995.52 | 138 / 180 | 79% | 51.11 | 340 / 430 |
| bladder | 71% | 15929.76 | 15 / 21 | 75% | 76.19 | 376 / 504 |
| uterus | 75% | 19825.78 | 127 / 170 | 65% | 51.16 | 297 / 459 |
| kidney | 52% | 8240.92 | 46 / 89 | 87% | 279.96 | 787 / 901 |
| liver | 35% | 4434.24 | 78 / 226 | 95% | 178.78 | 384 / 406 |
| esophagus | 52% | 9320.14 | 748 / 1445 | 70% | 58.51 | 129 / 183 |
| prostate | 38% | 6433.49 | 93 / 245 | 76% | 47.62 | 384 / 502 |
| skin | 51% | 9410.25 | 928 / 1809 | 63% | 51.48 | 297 / 472 |
| intestine | 55% | 10419.02 | 532 / 966 | 59% | 53.71 | 310 / 527 |
| stomach | 42% | 6816.84 | 152 / 359 | 69% | 61.69 | 198 / 286 |
| adipose | 100% | 72786.33 | 1200 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 118.45 | 79 / 80 |
| blood vessel | 96% | 55931.64 | 1284 / 1335 | 0% | 0 | 0 / 0 |
| brain | 17% | 2401.05 | 454 / 2642 | 74% | 68.54 | 520 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 58.01 | 26 / 29 |
| adrenal gland | 26% | 2474.60 | 66 / 258 | 60% | 60.57 | 139 / 230 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 63.13 | 38 / 45 |
| heart | 52% | 10625.84 | 445 / 861 | 0% | 0 | 0 / 0 |
| muscle | 51% | 8132.55 | 411 / 803 | 0% | 0 | 0 / 0 |
| spleen | 15% | 1709.09 | 37 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 155.22 | 10 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006914 | Biological process | autophagy |
| GO_0010506 | Biological process | regulation of autophagy |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005777 | Cellular component | peroxisome |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005739 | Cellular component | mitochondrion |
| Gene name | DEPP1 |
| Protein name | Protein DEPP1 (Decidual protein induced by progesterone) (Fasting-induced gene protein) (FIG) DEPP autophagy regulator 1 |
| Synonyms | DEPP C10orf10 FIG |
| Description | FUNCTION: Acts as a critical modulator of FOXO3-induced autophagy via increased cellular ROS. . |
| Accessions | X6RKE0 ENST00000298295.4 Q9NTK1 ENST00000448778.1 |